New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
07:09 EDTALIMAlimera Sciences resubmits NDA for Iluvien
Alimera Sciences has resubmitted its New Drug Application for Iluvien to the FDA. At this time, Alimera awaits the FDA's acceptance of the resubmission and a Prescription Drug User Fee Act date.
News For ALIM From The Last 14 Days
Check below for free stories on ALIM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ALIM

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use